Series A Funded Startups in Belgium
The largest disclosed Series A in this Belgium slice is Coultreon Biopharma’s $125M (2026-04-28), which dwarfs the rest of the disclosed rounds in the tabl…
The largest disclosed Series A in this Belgium slice is Coultreon Biopharma’s $125M (2026-04-28), which dwarfs the rest of the disclosed rounds in the table; the next-largest disclosed amounts are PanTera at $110M (2024-09-11) and Augustine Therapeutics at $84M (2025-03-24). At the other extreme, the smallest disclosed round is IONNYK’s $1M (2022-01-27), while two rounds are not sized publicly: NGRAVE ($—, 2023-07-15) and OTIV ($—, 2023-01-12).
Geographically and temporally, the list concentrates around Flemish locations (e.g., Ghent/Oost-Vlaanderen appears repeatedly with entries like Timefold 2026-06-23 and Tekst 2026-05-07), and AI shows up in multiple rounds across different cities (e.g., Superlinear $7M on 2026-01-13; Henchman $7M on 2023-03-02; TechWolf $11M on 2022-05-10; Soda $14M on 2021-02-02). The rounds span 2021-02-02 (Soda) through 2026-06-23 (Timefold), with the most recent entry dated 2026-06-23.
Most recent rounds
48 shownRelated listings
Frequently asked
Which disclosed round is the outlier in size, and what does it imply versus the rest of the table?
Coultreon Biopharma’s $125M (Series A, 2026-04-28) is the only disclosed round above $100M, followed by PanTera at $110M (2024-09-11) and Augustine Therapeutics at $84M (2025-03-24). That creates a clear top-heavy distribution among disclosed amounts.
Are there notable smallest-size or “not disclosed” cases that could distort size comparisons?
The smallest disclosed amount is IONNYK at $1M (2022-01-27). Two entries are not sized publicly in the table—NGRAVE (undisclosed, 2023-07-15) and OTIV (undisclosed, 2023-01-12)—so any “average round size” analysis would need to exclude or impute them.
Do certain sectors recur often enough to signal a theme in Belgium Series A activity here?
Artificial Intelligence appears across multiple rounds and geographies, including Superlinear ($7M, 2026-01-13), Henchman ($7M, 2023-03-02), TechWolf ($11M, 2022-05-10), and Soda ($14M, 2021-02-02). Biotechnology is also repeatedly represented with Coultreon Biopharma ($125M, 2026-04-28), Augustine Therapeutics ($84M, 2025-03-24), and PanTera ($110M, 2024-09-11).
Is there a city-level concentration, or are rounds spread across Belgium’s regions?
Ghent (Oost-Vlaanderen) recurs with multiple Series A closings such as Timefold ($13M, 2026-06-23), Tekst ($14M, 2026-05-07), and Donna ($5M, 2025-12-02). Antwerp (Antwerpen) also appears repeatedly, including D-CRBN ($20M, 2026-05-26) and Venly ($23M, 2022-04-08), indicating stronger clustering than a purely even spread.
How “recent” is this dataset, and what are the temporal edges of the shown rounds?
The newest round shown is Timefold’s Series A on 2026-06-23 ($13M), while the oldest is Soda’s Series A on 2021-02-02 ($14M). That five-year window means conclusions should separate the 2021–2023 entries from the 2024–2026 entries rather than treating the list as one uniform wave.
Within this page, which sector/city pairings appear more than once and could be prioritized for outreach or diligence?
Several AI companies recur in the same named geography class—for example, Ghent appears with multiple AI rounds including TechWolf ($11M, 2022-05-10) and Henchman ($7M, 2023-03-02), while Brussels is also repeated for AI such as Superlinear ($7M, 2026-01-13) and Soda ($14M, 2021-02-02). Biotechnology similarly shows repeated high-value sizing in different cities, including Coultreon Biopharma in Heverlee ($125M, 2026-04-28) and PanTera in Mol ($110M, 2024-09-11).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.